{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:00:41Z","timestamp":1784001641383,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Math Biol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11538-026-01643-1","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:26:29Z","timestamp":1775712389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vascular-Coupled Modeling of Treatment Resistance in Tyrosine Kinase Inhibitor Therapy: Parameter Estimation and Phase-Dependent Sensitivity Analysis"],"prefix":"10.1007","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6193-9471","authenticated-orcid":false,"given":"Mohammed","family":"El Hammani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidi Mohamed","family":"Douiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"El Harraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Aguedjig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"4","key":"1643_CR1","first-page":"618","volume":"240","author":"T Alarc\u00f3n","year":"2006","unstructured":"Alarc\u00f3n T, Byrne HM, Maini PK (2006) Towards the multiscale modelling of vegf-induced angiogenesis and tumour growth. J Theor Biol 240(4):618\u2013635","journal-title":"J Theor Biol"},{"key":"1643_CR2","unstructured":"Aguedjig H, Douiri SM, El\u00a0Harraki I, El\u00a0Hammani M (2025) A vascularized ODE model for patient-specific prediction of treatment resistance in gastrointestinal stromal tumors. Mathematical Modeling and Computing x(x), 1\u201312. In press"},{"key":"1643_CR3","volume-title":"Cancer Chemotherapy: Basic Science to the Clinic","author":"R Airley","year":"2009","unstructured":"Airley R (2009) Cancer Chemotherapy: Basic Science to the Clinic, 1st edn. John Wiley & Sons, Chichester, UK","edition":"1"},{"issue":"3","key":"1643_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc2325","volume":"8","author":"ARA Anderson","year":"2008","unstructured":"Anderson ARA, Quaranta V (2008) Integrative mathematical oncology. Nat Rev Cancer 8(3):227\u2013234. https:\/\/doi.org\/10.1038\/nrc2325","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1643_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0895-7177(96)00174-4","volume":"24","author":"HM Byrne","year":"1996","unstructured":"Byrne HM, Chaplain MAJ (1996) Modelling the role of cell-cell adhesion in the growth and development of carcinomas. Math Comput Model 24(12):1\u201317. https:\/\/doi.org\/10.1016\/S0895-7177(96)00174-4","journal-title":"Math Comput Model"},{"issue":"12","key":"1643_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s43588-022-00377-z","volume":"2","author":"JD Butner","year":"2022","unstructured":"Butner JD, Dogra P, Chung C, Pasqualini R, Arap W, Lowengrub J, Cristini V, Wang Z (2022) Mathematical modeling of cancer immunotherapy for personalized clinical translation. Nature Computational Science 2(12):785\u2013796. https:\/\/doi.org\/10.1038\/s43588-022-00377-z","journal-title":"Nature Computational Science"},{"issue":"5","key":"1643_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ctrv.2010.11.003","volume":"37","author":"J-Y Blay","year":"2011","unstructured":"Blay J-Y (2011) A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST. Cancer Treat Rev 37(5):373\u2013384. https:\/\/doi.org\/10.1016\/j.ctrv.2010.11.003","journal-title":"Cancer Treat Rev"},{"key":"1643_CR8","doi-asserted-by":"crossref","unstructured":"Coclite A, Eccher RM, Possenti L, Vitullo P, Zunino P (2025) Mathematical modeling and sensitivity analysis of hypoxia-activated drugs. arXiv:2507.15642","DOI":"10.3934\/math.20251130"},{"key":"1643_CR9","doi-asserted-by":"crossref","unstructured":"Chen Y-f, Fu L-w (2011) Mechanisms of acquired resistance to tyrosine kinase inhibitors. Acta Pharmaceutica Sinica B 1(4), 197\u2013207","DOI":"10.1016\/j.apsb.2011.10.007"},{"issue":"5","key":"1643_CR10","doi-asserted-by":"publisher","first-page":"0217332","DOI":"10.1371\/journal.pone.0217332","volume":"14","author":"P Cumsille","year":"2019","unstructured":"Cumsille P, Godoy M, Gerdtzen ZP, Conca C (2019) Parameter estimation and mathematical modeling for the quantitative description of therapy failure due to drug resistance in gastrointestinal stromal tumor metastasis to the liver. PLoS ONE 14(5):0217332","journal-title":"PLoS ONE"},{"key":"1643_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.bioeng.8.061505.095807","volume":"8","author":"MAJ Chaplain","year":"2006","unstructured":"Chaplain MAJ, McDougall SR, Anderson ARA (2006) Mathematical modeling of tumor-induced angiogenesis. Annu Rev Biomed Eng 8:233\u2013257","journal-title":"Annu Rev Biomed Eng"},{"key":"1643_CR12","doi-asserted-by":"publisher","unstructured":"Celora GL, Nixson R, Pitt-Francis JM, Maini PK, Byrne HM (2024) Characterising cancer cell responses to cyclic hypoxia using mathematical modelling. Bulletin of Mathematical Biology 86(145) https:\/\/doi.org\/10.1007\/s11538-024-01359-0","DOI":"10.1007\/s11538-024-01359-0"},{"key":"1643_CR13","unstructured":"Drasdo D, H\u00f6hme S (2002) Individual-based approaches to birth and death in avascular tumors"},{"key":"1643_CR14","volume-title":"Cancer: Principles and Practice of Oncology","author":"VT DeVita","year":"2011","unstructured":"DeVita VT, Lawrence TS, Rosenberg SA (2011) Cancer: Principles and Practice of Oncology, 9th edn. Lippincott Williams & Wilkins, Philadelphia","edition":"9"},{"key":"1643_CR15","doi-asserted-by":"publisher","unstructured":"D\u00e9nes A, Marzban S, R\u00f6st G (2021) Global analysis of a cancer model with drug resistance due to Lamarckian induction and microvesicle transfer. Journal of Theoretical Biology 527, 110812 https:\/\/doi.org\/10.1016\/j.jtbi.2021.110812","DOI":"10.1016\/j.jtbi.2021.110812"},{"key":"1643_CR16","doi-asserted-by":"crossref","unstructured":"D\u00e9nes A, R\u00f6st G (2020) Global analysis of a cancer model with drug resistance due to microvesicle transfer. In: Trends in Biomathematics: Modeling Cells, Flows, Epidemics, and the Environment vol. 19, pp. 71\u201380","DOI":"10.1007\/978-3-030-46306-9_5"},{"issue":"9544","key":"1643_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","volume":"368","author":"GD Demetri","year":"2006","unstructured":"Demetri GD, Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CDM, George S, Bello CL, Huang X, Baum CM, Casali PG (2006) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: A randomised controlled trial. The Lancet 368(9544):1329\u20131338. https:\/\/doi.org\/10.1016\/S0140-6736(06)69446-4","journal-title":"The Lancet"},{"key":"1643_CR18","doi-asserted-by":"crossref","unstructured":"El\u00a0Hammani M, Douiri SM, El\u00a0Harraki I, Aguedjig H (2026) Mathematical and numerical analysis of chemotherapy resistance in tumors: Modeling integrating darwinian, lamarckian, and microvesicle-mediated mechanisms with the weno5 scheme. Communications on Applied Mathematics and Computation, 1\u201333","DOI":"10.1007\/s42967-025-00540-z"},{"issue":"327","key":"1643_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1126\/scitranslmed.aad7842","volume":"8","author":"PM Enriquez-Navas","year":"2016","unstructured":"Enriquez-Navas PM, Kam Y, Das T, Hassan S, Silva A, Foroutan P, Ruiz E, Martinez G, Minton S, Gillies RJ, Gatenby RA (2016) Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer. Science Translational Medicine 8(327):327\u201324. https:\/\/doi.org\/10.1126\/scitranslmed.aad7842","journal-title":"Science Translational Medicine"},{"key":"1643_CR20","doi-asserted-by":"publisher","unstructured":"Frieboes HB, Zheng X, Sun C-H, Tromberg BJ, Gatenby R, Cristini V (2007) Computer simulation of glioma growth and morphology. NeuroImage 37, 59\u201370 https:\/\/doi.org\/10.1016\/j.neuroimage.2007.03.008","DOI":"10.1016\/j.neuroimage.2007.03.008"},{"issue":"11\u201312","key":"1643_CR21","first-page":"1727","volume":"63","author":"JH Goldie","year":"1979","unstructured":"Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63(11\u201312):1727\u20131733","journal-title":"Cancer Treat Rep"},{"issue":"17","key":"1643_CR22","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1158\/0008-5472.CAN-17-2649","volume":"82","author":"JA Gallaher","year":"2018","unstructured":"Gallaher JA, Enriquez-Navas PM, Luddy KA, Gatenby RA, Anderson ARA (2018) Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies. Can Res 82(17):2293\u20132302. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2649","journal-title":"Can Res"},{"issue":"6921","key":"1643_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/421321a","volume":"421","author":"RA Gatenby","year":"2003","unstructured":"Gatenby RA, Maini PK (2003) Mathematical oncology: cancer summed up. Nature 421(6921):321. https:\/\/doi.org\/10.1038\/421321a","journal-title":"Nature"},{"issue":"19","key":"1643_CR24","first-page":"4770","volume":"59","author":"P Hahnfeldt","year":"1999","unstructured":"Hahnfeldt P, Panigrahy D, Folkman J, Hlatky L (1999) Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Can Res 59(19):4770\u20134775","journal-title":"Can Res"},{"issue":"1","key":"1643_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0951-8320(96)00002-6","volume":"52","author":"T Homma","year":"1996","unstructured":"Homma T, Saltelli A (1996) Importance measures in global sensitivity analysis of nonlinear models. Reliability Engineering & System Safety 52(1):1\u201317","journal-title":"Reliability Engineering & System Safety"},{"issue":"10","key":"1643_CR26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13(10):714\u2013726. https:\/\/doi.org\/10.1038\/nrc3599","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1643_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"1643_CR28","doi-asserted-by":"publisher","unstructured":"Hamis S, Yates J, Chaplain MA, Powathil GG (2021) Targeting cellular dna damage responses in cancer: An in vitro-calibrated agent-based model simulating monolayer and spheroid treatment responses to atr-inhibiting drugs. Bulletin of Mathematical Biology 83(103) https:\/\/doi.org\/10.1007\/s11538-021-00935-y","DOI":"10.1007\/s11538-021-00935-y"},{"issue":"4","key":"1643_CR29","first-page":"811","volume":"6","author":"D Kirschner","year":"2009","unstructured":"Kirschner D, Pienaar E, Marino S, Linderman JJ (2009) Uncertainty and sensitivity analysis applied to biological models. Math Biosci Eng 6(4):811\u2013824","journal-title":"Math Biosci Eng"},{"key":"1643_CR30","doi-asserted-by":"publisher","unstructured":"Lorz A, Botesteanu D-A, Levy D (2017) Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth. Journal of Theoretical Biology 427, 98\u2013112 https:\/\/doi.org\/10.1016\/j.jtbi.2017.06.005","DOI":"10.1016\/j.jtbi.2017.06.005"},{"issue":"2","key":"1643_CR31","first-page":"151","volume":"34","author":"G Lefebvre","year":"2017","unstructured":"Lefebvre G, Cornelis F, Cumsille P, Colin T, Poignard C, Saut O (2017) Spatial modelling of tumour drug resistance: the case of gist liver metastases. Mathematical medicine and biology a journal of the IMA 34(2):151\u2013176","journal-title":"Mathematical medicine and biology a journal of the IMA"},{"issue":"1","key":"1643_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00285-021-01628-9","volume":"83","author":"U Ledzewicz","year":"2021","unstructured":"Ledzewicz U, d\u2019Onofrio A, Sch\u00e4ttler H (2021) Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling. J Math Biol 83(1):1\u201332. https:\/\/doi.org\/10.1007\/s00285-021-01628-9","journal-title":"J Math Biol"},{"key":"1643_CR33","doi-asserted-by":"publisher","unstructured":"Lecca P (2021) Control theory and cancer chemotherapy: How they interact. Frontiers in Bioengineering and Biotechnology 8, 621269 https:\/\/doi.org\/10.3389\/fbioe.2020.621269","DOI":"10.3389\/fbioe.2020.621269"},{"issue":"1","key":"1643_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1088\/0951-7715\/23\/1\/R01","volume":"23","author":"JS Lowengrub","year":"2010","unstructured":"Lowengrub JS, Frieboes HB, Jin F, Chuang Y-L, Li X, Macklin P, Wise SM, Cristini V (2010) Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity 23(1):1\u201391","journal-title":"Nonlinearity"},{"issue":"1","key":"1643_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11538-014-0046-4","volume":"77","author":"A Lorz","year":"2015","unstructured":"Lorz A, Lorenzi T, Hochberg ME, Clairambault J, Perthame B (2015) Effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors. Bull Math Biol 77(1):1\u201322. https:\/\/doi.org\/10.1007\/s11538-014-0046-4","journal-title":"Bull Math Biol"},{"issue":"1","key":"1643_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1051\/mmnp\/20149110","volume":"9","author":"U Ledzewicz","year":"2014","unstructured":"Ledzewicz U, Sch\u00e4ttler H (2014) A review of optimal chemotherapy protocols: from MTD towards metronomic therapy. Mathematical Modelling of Natural Phenomena 9(1):131\u2013152. https:\/\/doi.org\/10.1051\/mmnp\/20149110","journal-title":"Mathematical Modelling of Natural Phenomena"},{"issue":"2","key":"1643_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/00401706.1991.10484804","volume":"33","author":"MD Morris","year":"1991","unstructured":"Morris MD (1991) Factorial sampling plans for preliminary computational experiments. Technometrics 33(2):161\u2013174","journal-title":"Technometrics"},{"key":"1643_CR38","unstructured":"Martin TA, Ye L, Sanders AJ, Lane J, Jiang WG (2013) Cancer invasion and metastasis: molecular and cellular perspective. In: Madame Curie Bioscience Database [Internet]. Landes Bioscience, Austin, TX, USA"},{"issue":"4","key":"1643_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/cncr.20862","volume":"103","author":"B Nilsson","year":"2005","unstructured":"Nilsson B, B\u00fcmming P, Meis-Kindblom JM, Od\u00e9n A, Dortok A, Gustavsson B, Sablinska K, Kindblom L-G (2005) Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western sweden. Cancer 103(4):821\u2013829. https:\/\/doi.org\/10.1002\/cncr.20862","journal-title":"Cancer"},{"key":"1643_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.envsoft.2016.02.008","volume":"79","author":"F Pianosi","year":"2016","unstructured":"Pianosi F, Beven K, Freer J, Hall JW, Rougier J, Stephenson DB, Wagener T (2016) Sensitivity analysis of environmental models: A systematic review with practical workflow. Environmental Modelling & Software 79:214\u2013232","journal-title":"Environmental Modelling & Software"},{"issue":"3","key":"1643_CR41","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/cancers12030731","volume":"12","author":"C Pottier","year":"2020","unstructured":"Pottier C, Fresnais M, Gilon M, J\u00e9rusalem G, Longuesp\u00e9e R, Sounni NE (2020) Tyrosine kinase inhibitors in cancer: breakthrough and challenges of targeted therapy. Cancers 12(3):731","journal-title":"Cancers"},{"issue":"8","key":"1643_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","volume":"7","author":"E Pasquier","year":"2010","unstructured":"Pasquier E, Kavallaris M, Andr\u00e9 N (2010) Metronomic chemotherapy: new rationale for new directions. Nat Rev Clin Oncol 7(8):455\u2013465. https:\/\/doi.org\/10.1038\/nrclinonc.2010.82","journal-title":"Nat Rev Clin Oncol"},{"issue":"15","key":"1643_CR43","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/bioinformatics\/btp358","volume":"25","author":"A Raue","year":"2009","unstructured":"Raue A, Kreutz C, Maiwald T, Bachmann J, Schilling M, Klingm\u00fcller U, Timmer J (2009) Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics 25(15):1923\u20131929. https:\/\/doi.org\/10.1093\/bioinformatics\/btp358","journal-title":"Bioinformatics"},{"key":"1643_CR44","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 71(3), 209\u2013249 https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"issue":"1\u20133","key":"1643_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejphar.2009.06.073","volume":"625","author":"A Swierniak","year":"2009","unstructured":"Swierniak A, Kimmel M, Smieja J (2009) Mathematical modeling as a tool for planning anticancer therapy. Eur J Pharmacol 625(1\u20133):108\u2013121. https:\/\/doi.org\/10.1016\/j.ejphar.2009.06.073","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1643_CR46","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3934\/mbe.2016040","volume":"13","author":"H Sch\u00e4ttler","year":"2016","unstructured":"Sch\u00e4ttler H, Ledzewicz U, Rebarber R et al (2016) Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity. Math Biosci Eng 13(6):1083\u20131104. https:\/\/doi.org\/10.3934\/mbe.2016040","journal-title":"Math Biosci Eng"},{"issue":"4","key":"1643_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1023\/A:1008202821328","volume":"11","author":"R Storn","year":"1997","unstructured":"Storn R, Price K (1997) Differential evolution - a simple and efficient heuristic for global optimization over continuous spaces. J Global Optim 11(4):341\u2013359. https:\/\/doi.org\/10.1023\/A:1008202821328","journal-title":"J Global Optim"},{"key":"1643_CR48","doi-asserted-by":"crossref","unstructured":"Shammas T, Peiris MN, Meyer AN, Donoghue DJ (2025) Bcr-abl: The molecular mastermind behind chronic myeloid leukemia. Cytokine & Growth Factor Reviews","DOI":"10.1016\/j.cytogfr.2025.05.001"},{"key":"1643_CR49","volume-title":"The Biology of Cancer","author":"RA Weinberg","year":"2007","unstructured":"Weinberg RA (2007) The Biology of Cancer, 1st edn. Garland Science, New York","edition":"1"},{"issue":"10","key":"1643_CR50","first-page":"720","volume":"8","author":"A Yin","year":"2019","unstructured":"Yin A, Moes DJA, Hasselt JG, Swen JJ, Guchelaar H-J (2019) A review of mathematical models for tumor dynamics and treatment resistance evolution of solid tumors CPT pharmacometrics & systems pharmacology 8(10):720\u2013737","journal-title":"A review of mathematical models for tumor dynamics and treatment resistance evolution of solid tumors CPT pharmacometrics & systems pharmacology"},{"issue":"8","key":"1643_CR51","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1177\/0272989X251353211","volume":"45","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Lipa N, Alagoz O (2025) A scoping review on calibration methods for cancer simulation models. Med Decis Making 45(8):965\u2013975. https:\/\/doi.org\/10.1177\/0272989X251353211. (Epub 2025 Aug 11)","journal-title":"Med Decis Making"}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-026-01643-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11538-026-01643-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-026-01643-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:48:47Z","timestamp":1780163327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11538-026-01643-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1643"],"URL":"https:\/\/doi.org\/10.1007\/s11538-026-01643-1","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial or non-financial interests that are directly or indirectly related to the work submitted for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable. This study uses previously published clinical data and does not involve human participants or animals directly.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"77"}}